In RMS cells, HDAC6 regulates cytoskeletal dynamics through the Rho family GTPase Rac1 to promote tumor cell migration and invasion, and targeting the HDAC6-Rac1 axis may be a therapeutic target for RMS(Pham et al., 2021). The gene discussed is HDAC6; the disease is neoplasm.